Helene Laude | Malnutrition | Best Researcher Award

Dr. Helene Laude | Malnutrition | Best Researcher Award

Institute Pasteur | France

Dr. Helene Laude, MD, PhD, is a distinguished French physician-scientist recognized for her expertise in virology, immunology, and infectious diseases. Currently affiliated with the Institute Pasteur, she has made significant contributions to understanding viral pathogenesis, host immunity, and infection-related carcinogenesis. Her research has advanced knowledge on viruses such as SARS-CoV-2, Monkeypox, Zika, and various oncogenic viruses including Merkel polyomavirus and cytomegalovirus. Dr. Helene Laude has served as principal investigator for major clinical and immunological studies, focusing on mucosal immunity, biomarker discovery, and population-based cohort investigations. With 998 citations by 853 documents, 32 publications, and an h-index of 15, her scholarly impact underscores her leadership in translational virology and public health research. Her publications in The Lancet Oncology, Scientific Reports, Frontiers in Immunology, and Cell Host & Microbe highlight her dedication to advancing biomedical science. A respected expert and reviewer for leading organizations such as ANRS, INCa, and IARC, she contributes to global evaluations on viral carcinogenicity and diagnostic innovation. Beyond research, Dr. Helene Laude is actively involved in academic teaching at renowned institutions including the Institute Pasteur, Sorbonne University, and Paris Descartes University, mentoring future scientists and medical professionals in vaccinology, virology, and cancer immunology. Her achievements exemplify excellence in clinical investigation and molecular medicine, bridging laboratory discoveries with human health applications to enhance global infectious disease preparedness and cancer prevention.

Profiles: Scopus 

Featured Publications

Karagas, M. R., Kaldor, J., Michaelis, M., Muchengeti, M. M., Alfaiate, D., Argirion, I., Chen, X., Cunha, C., Hantz, S., Koljonen, V., Laude, H. C., Lui, W. O., Nevels, M. M., O’Brien, T. R., Scheurer, M. E., Touze, A., Wiemels, J. L., Benbrahim-Tallaa, L., de Conti, A., Facchin, C., Madia, F., Pasqual, E., Wedekind, R., Aguilera-Buenosvinos, I., Clifford, G., Deng, X., Dongoran, R. A., Ezzemni, S., Huang, Y., Suonio, E., Zhai, Y., Mattock, H., Schubauer-Berigan, M. K., & Kunzmann, A. T. (2025). Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus. Lancet Oncology, S1470-2045(25)00403-6.

Beeker, L., Obadia, T., Bloch, E., Garcia, L., Le Fol, M., Charmet, T., Arowas, L., Artus, R., Cheny, O., Cheval, D., Dahoumane, Y., Delhaye, M., Ergen, D., Essaidani, M., Fanaud, C., Fernandes Pellerin, S., Jolly, N., Laude, H., Roux, E., Samson, M., Sangari, L., Ungeheuer, M. N., Vacant, S., Zayoud, A., Donnadieu, F., Pelleau, S., Galmiche, S., Fontanet, A., & White, M. (2025). Correlates of protection against symptomatic COVID-19: The CORSER 5 case-control study. Open Forum Infectious Diseases, 12(1).

Combes, J. D., Didelot, J. M., Radenne, S., Zaegel-Faucher, O., Lesage, A. C., Siproudhis, L., Piroth, L., Marchand, L., Heard, I., Hoyeau, N., Henno, S., Darragh, T. M., Alberts, C. J., Clifford, G. M., & Etienney, I.; ANRS-EP57-APACHES Study group. (2024). Cumulative detection of anal high-grade squamous intraepithelial lesions over 2-year follow-up in men who have sex with men living with human immunodeficiency virus in France. Journal of Infectious Diseases, 230(1).

Martinez, F. J., Guillotte-Blisnick, M., Huon, C., England, P., Popovici, J., Laude, H., Arowas, L., Ungeheuer, M. N., Reimer, J. M., Carter, D., Reed, S., Mukherjee, P., Chauhan, V. S., & Chitnis, C. E. (2023). Immunogenicity of a Plasmodium vivax vaccine based on the Duffy binding protein formulated using adjuvants compatible for use in humans. Scientific Reports, 13(1), 13904.

Cuche, C., Mastrogiovanni, M., Juzans, M., Laude, H., Ungeheuer, M. N., Krentzel, D., Gariboldi, M. I., Scott-Algara, D., Madec, M., Goyard, S., Floch, C., Chauveau-Le Friec, G., Lafaye, P., Renaudat, C., Le Bidan, M., Micallef, C., Schmutz, S., Mella, S., Novault, S., Hasan, M., Duffy, D., Di Bartolo, V., & Alcover, A. (2023). T cell migration and effector function differences in familial adenomatous polyposis patients with APC gene mutations. Frontiers in Immunology, 14, 1163466.

 

Mike Studer | Health and Wellness | Excellence in Innovation

Dr. Mike Studer | Health and Wellness | Excellence in Innovation

PT, DPT, FAPTA, Touro University Nevada, United States 

Dr. Mike Studer, PT, DPT, MHS, FAPTA, is a nationally recognized physical therapist specializing in geriatrics and neurologic rehabilitation. With over 30 years of clinical, academic, and leadership experience, he’s a passionate educator, researcher, and advocate. Dr. Studer has authored books, developed certifications, and mentored countless professionals, aiming to enhance mobility and cognitive health across the lifespan. He currently serves as adjunct faculty at multiple institutions and co-owns Spark Rehabilitation and Wellness in Oregon.

Profile

Google Scholar

🎓 Education 📘

Mike Studer earned his Doctor of Physical Therapy (DPT) in 2021 from the College of St. Scholastica with a perfect 4.0 GPA. He holds a Master of Health Science in Physical Therapy with a Neurologic Emphasis (1998) from the Krannert School, graduating Magna Cum Laude. He also obtained his Bachelor of Health Science in Physical Therapy in 1991 from the University of Missouri, where he graduated Summa Cum Laude.

💼 Experience 👨‍⚕️

Dr. Studer’s professional journey spans clinical care, academic teaching, and entrepreneurship. He co-founded Spark Rehabilitation and Wellness (2022–present), was President of Northwest Rehabilitation Associates (2004–2020), and has held teaching roles at Oregon State University, Touro University, and UNLV. His clinical posts include Salem Hospital and Younker Rehabilitation Center, specializing in stroke, geriatrics, and neurologic rehab.

🔬 Research Interest 🧬

Mike Studer’s research interests focus on neuroplasticity, stroke rehabilitation, fall prevention, dual-task training, and aging. He explores the intersection of motor learning and cognitive performance, applying behavioral economics to therapeutic outcomes. His work contributes significantly to understanding balance, mobility, and rehabilitation strategies for older adults and individuals with neurologic conditions.

🏅 Awards & Recognition 🏆

A respected figure in his field, Dr. Studer holds numerous certifications including NCS, CEEAA, CSST, and CBFP. He was honored as a Fellow of the APTA (FAPTA) and has received national and international recognition for his scholarly contributions, including invited commentary, editorial roles, and patent-pending innovations in dual-task HIIT rehabilitation.

📚 Publications 

Studer, M. (2025). Practical Applications in Lifespan and Healthspan. Journal of Rehabilitation Practices and Research. In Press.

Studer, M., Irwin, K., Wingood, M. (2025). The Pharmacists of Physical Activity. Healthcare. In Press.

Scales, R., Studer, M., et al. (2025). Balance Confidence in Early Cardiac Rehab. Archives of Physical Medicine and Rehabilitation.

Moore, K., et al., including Studer, M. (2024). Posturography with Machine Learning. Medicine & Science in Sports & Exercise.

Studer, M. (2024). Invited Commentary: Balance Perturbation in Parkinson’s. J Neuro Phys Ther. Cited by 6 articles.

Studer, M., Shubert, T. (2024). Behavioral Economics in Rehab. Physical Therapy.

Silva-Batista, C., Studer, M., et al. (2023). Mobility Rehab Feedback System. J Neuroeng Rehabil.

Vitório, R., Studer, M., et al. (2021). Mobility Rehab System Effectiveness. Frontiers in Neurology. Cited by 24 articles.

Studer, M. (2021). Exercise in Reality – WHO Guidelines. Gerinotes.

Studer, M. (2018). Dual Task Rehabilitation. Topics in Geriatric Rehabilitation.

Shumway-Cook, A., Studer, M., et al. (2013). Dynamic Gait Index Scoring Expansion. Physical Therapy Journal. Cited by 190+ articles.

Studer, M. (2007). Rehabilitation of Executive Function. J Neurol Phys Ther.

✅ Conclusion

Dr. Mike Studer is a prime candidate for the Excellence in Innovation Award, with a career that exemplifies creative, evidence-based problem-solving in physical therapy and rehabilitation. His work is not only scientifically rigorous but also clinically transformative, making a meaningful difference in the lives of patients and the professionals who serve them. With continued efforts in global collaboration and commercialization, Dr. Studer is well-positioned to shape the future of innovative healthcare delivery.